Bimacrocylic HCV NS3 protease inhibitors
US8703700B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 24, 2010 |
| Grant date | Apr 22, 2014 |
| Priority date | — |
| Expiry date | Nov 9, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Inhibitors of the hepatitis C virus (HCV) NS3 protease are provided. In particular, bimacrocyclic compounds and their pharmaceutical compositions for the treatment of HCV infections are provided. Methods of making the bimacrocyclic compounds and their pharmaceutical compositions, and methods of using the compounds for treating HCV infections are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.